Ken Fisher's XBI Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 1,412 shares of State Street SPDR S&P Biotech ETF (XBI) worth $222,711, representing 0.00% of the portfolio. First purchased in 2020-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Ken Fisher has maintained this position in XBI for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2020, adding 1,435 shares. Largest reduction occurred in Q3 2020, reducing 2,573 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's State Street SPDR S&P Biotech ETF (XBI) Holding Value Over Time
Track share changes against reported price movement
Quarterly State Street SPDR S&P Biotech ETF (XBI) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +1,412 | New Buy | 1,412 | $157.73 |
| Q1 2021 | -1,435 | Sold Out | 0 | $0.00 |
| Q4 2020 | +1,435 | New Buy | 1,435 | $140.77 |
| Q3 2020 | -2,573 | Sold Out | 0 | $0.00 |
| Q2 2020 | +2,573 | New Buy | 2,573 | $111.93 |
Ken Fisher's State Street SPDR S&P Biotech ETF Investment FAQs
Ken Fisher first purchased State Street SPDR S&P Biotech ETF (XBI) in Q2 2020, acquiring 2,573 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held State Street SPDR S&P Biotech ETF (XBI) for 5 quarters since Q2 2020.
Ken Fisher's largest addition to State Street SPDR S&P Biotech ETF (XBI) was in Q2 2020, adding 2,573 shares worth $288,000.
According to the latest 13F filing for Q3 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 1,412 shares of State Street SPDR S&P Biotech ETF (XBI), valued at approximately $222,711.
As of the Q3 2026 filing, State Street SPDR S&P Biotech ETF (XBI) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in State Street SPDR S&P Biotech ETF (XBI) was 2,573 shares, as reported at the end of Q2 2020.